Clinical Trial

Immunogenomic Analyses of Pediatric Catatonia

Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
Rady Children's Institute for Genomic Medicine seeks to understand the genomes and immune systems in 40 children and adolescents who are admitted to Rady Children's Hospital San Diego with a catatonia diagnosis. Cutting-edge genome and protein sequencing technology will be used to better understand how immunological and genetic assessments may improve the ability to identify the cause of catatonia and impact care. The investigator also hopes to identify new genetic and/or autoimmune causes of catatonia that may inform new treatment for future patients.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2024-10-22.
Trial Details
NCT Number NCT06656572
Lead Sponsor Rady Pediatric Genomics & Systems Medicine Institute
Collaborators: Brain & Behavior Research Foundation
Conditions Catatonia
Enrollment 120 participants
Start Date 2024-12-01
Primary Completion 2026-09-01 (estimated)
Study Completion 2030-09-01 (estimated)
Updated on ClinicalTrials.gov 2024-11-14